We've found 843 total results

A Study of PTC923 in Participants With Phenylketonuria

The main purpose of this trial is to evaluate the efficacy of PTC923 in reducing blood phenylalanine (Phe) levels in participants with phenylketonuria as measured by mean change in blood Phe levels from baseline to Weeks 5 and 6 (that is, the average of each respect...

Age: Birth - 66+

Gender: All

Increasing Breast Cancer Screening in Chinese Immigrants

The long-term goal of this research is to increase breast cancer screening rates in NYC Chinese immigrants. The researchers plan to accomplish this objective by developing and testing a culturally- and linguistically-adapted Witness Project program for Chinese immigrant...

Age: 40 years - 66+

Gender: Female

Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia

Alopecia could be subdivided into two main groups of diseases: non-scarring alopecia, such as male pattern baldness, or alopecia areata (AA), in which hair follicles are preserved, yet quiescent, and scarring alopecia, also known as cicatricial alopecia (CA), in which h...

Age: 18 years - 66+

Gender: All

Neurocognition After Perturbed Sleep

Individuals with schizophrenia display a wide range of neurocognitive difficulties resulting in functional impairment and disability. Extensive evidence indicates insomnia and sleep disturbances play a substantial role in degrading cognitive functioning. However, the pu...

Age: 18 - 50 years

Gender: All

Investigation of the Pharmacokinetic Profile of Nanoemulsion CBD

The goal of the current study is to evaluate the bioavaibiltiy of nanoemulsion CBD in normal healthy Individuals. This is an open cross-over design study in healthy individuals to assess the safety and pharmacokinetic (PK) effects of nanoemulsion cannabidiol.

Age: 18 - 65 years

Gender: All

Dupilumab_Metastatic NSCLC

This is an Phase Ib/2 study, single arm, single cohort study to determine the safety and tolerability of Dupilumab with PD-(L)1 blockade for patients with relapsed/refractory metastatic NSCLC. For Phase 2, to determine the effect of adding IL-4Ra blockade to PD-(L)1...

Age: 18 years - 66+

Gender: All

Telehealth Referral to Improve Outcomes

Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called Vital...

Age: 18 years - 66+

Gender: All

Telehealth Referral to Improve Outcomes

Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called V...

Age: 18 years - 66+

Gender: All